Physician profile
Michael Langiulli
NPI 1992765440
$7,583.75
in general payments reported to CMS, 2019-2025
42 companies · $4,010 in 2025
The $4,010 reported for 2025 was more than what 90% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,138 · 2020: $423 · 2021: $495 · 2022: $98.81 · 2023: $684 · 2024: $735 · 2025: $4,010.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,769 · Food and Beverage: $2,660.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,768.99 |
| Food and Beverage | $2,659.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,868.32 | 2019-2025 | Jetstream Sc, General - Angiography, Avvigo Guidance System |
| Medtronic, INC. | $1,699.52 | 2025 | Onyx Frontier, Cobalt Dr Mri Surescan, Azure Xt Dr Mri Surescan |
| Novartis Pharmaceuticals Corporation | $649.50 | 2019-2025 | |
| Abbott Laboratories | $318.83 | 2019-2025 | Diamondback Coronary, Xience Skypoint |
| Merck Sharp & Dohme LLC | $281.21 | 2023-2025 | Verquvo |
| Sanofi-Aventis U.S. LLC | $257.64 | 2019-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $232.08 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $215.09 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $190.50 | 2019-2025 | Camzyos, Eliquis |
| Amgen INC. | $170.67 | 2019-2025 | Repatha, Repatha |
| Esperion Therapeutics, INC. | $148.78 | 2023-2025 | Nexletol |
| Astrazeneca Pharmaceuticals LP | $137.30 | 2019-2024 | Farxiga |
| Philips North America LLC | $137.15 | 2019-2023 | |
| Cardiovascular Systems INC. | $118.67 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $105.17 | 2019-2023 | Jardiance |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lexicon Pharmaceuticals, INC. | $80.32 | 2023-2024 | Inpefa |
| Inari Medical, INC. | $78.28 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abiomed | $77.86 | 2023-2025 | Impella |
| Irhythm Technologies, INC. | $75.38 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Alnylam Pharmaceuticals INC. | $75.27 | 2019-2025 | Amvuttra |
| Pfizer INC. | $71.78 | 2019-2022 | |
| Kestra Medical Technology Services, INC. | $54.38 | 2025 | Assure Wcd |
| Actelion Pharmaceuticals US, INC. | $53.46 | 2019 | |
| Preventice Services, LLC | $50.95 | 2021 | |
| Cvrx, INC. | $49.24 | 2023 | Barostim Neo System |
| Recor Medical INC | $42.35 | 2025 | Paradise Ultrasound Renal Denervation System |
| Xeris Pharmaceuticals, INC. | $40.76 | 2023-2024 | Keveyis |
| Bardy Diagnostics, INC. | $40.38 | 2019 | |
| Novo Nordisk INC | $34.42 | 2024-2025 | Wegovy, Rybelsus, Ozempic |
| Cardiva Medical, INC. | $27.97 | 2024 | Cardiva Vascade 6/7f Vcs |
| Kowa Pharmaceuticals America, INC. | $20.96 | 2023 | Livalo |
| Amarin Pharma, INC. | $19.90 | 2019 | |
| Becton, Dickinson and Company | $19.71 | 2025 | Rotarexs 6 F X 135 Cm |
| Teleflex LLC | $18.99 | 2025 | Chocolate |
| Bridgebio Pharma, INC. | $18.09 | 2025 | Attruby |
| Medtronic Vascular, INC. | $16.88 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.78 | 2025 | |
| Scpharmaceuticals INC. | $15.31 | 2024 | |
| Gilead Sciences, INC. | $14.20 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $13.97 | 2019 | |
| Getinge USA Sales, LLC | $13.50 | 2020 | |
| Medicomp INC | $13.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Langiulli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.